All treatment regimens showed a decrease in spondylitis severity compared to the vehicle treated group, which reached significance for the combination therapy (p = 0.031) and anti-TNF monotherapy groups (p = 0.031), while a numerical decrease was observed in the anti-IL17A monotherapy group without statistical significance (p = 0.164) (Figure 1b). Here, TNF is linked to spondylitis.